TFS HealthScience Case Studies
-
Driving Early-Phase Success In Advanced Solid Tumors Study
3/24/2025
A European biotech company collaborated with TFS HealthScience to conduct an early-phase clinical trial focusing on advanced and metastatic solid tumors.
-
Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies
3/24/2025
To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.
-
Streamlining Phase I/II Oncology Trials: A Global CRO Partnership
3/17/2025
Through strategic planning, adaptive trial execution, and proactive collaboration, TFS successfully navigated the complexities of this early-phase oncology study.
-
Tailored Solutions For A Global Phase III Neovascular AMD Study
3/17/2025
How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?
-
Optimizing Early-Stage Oncology
1/14/2025
A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.
-
Addressing Site Selection Challenges In DMD Gene Therapy Studies
1/14/2025
Effective site selection is critical for the success of DMD gene therapy trials. This study details innovative methodologies employed to streamline and improve site identification.